Patients Aged 70 or Older With Esophageal or EGJ Cancers Should Be Evaluated for Optimal Curative Therapy

A recent study found that patients over 70 with esophageal cancers benefited from “triple modality” surgery that included surgery, with five-year survival rates of 45%.